Journal of Psychoactive Drugs 2009: Vol 41 Index

2009·1.9 MB·English

Index
Volume 41 (1-4), 2009
AUTHORS
Aase, Darrin M. 41 (4): 349-54. Evren, Bilge 41 (1): 85-92.
Abbott, Patrick J. 41 (4): 379-85. Evren, Cuneyt 41 (1): 85-92.
Abramsohn, Yali 41 (3): 249-53. Fackler, Jennifer 41 (3): 219-26.
Adelson, Miriam 41 (3): 249-53. Ferrari, Joseph R. 41 (4): 349-54.
Agar, Michael H. 41 (2): 145-52, (3): 285-96. Ferrer, Mirtha 41 (2): 105-12.
Albertson, Dawn N. 41 (3): 213-17. Forman, Robert F. 41 (3): 305-07.
Alexander-Eitzman, Ben 41 (4): 369-77 Garland, Eric L. 41 (4): 337-47.
Astone-Twerell, Janetta 41 (4): 355-61. Gascon, Diana J. 41 (1): 99-102.
Baciewicz, Gloria 41 (1): 93-98 Geppert, Cynthia 41 (1): 49-60.
Barbosa, Paulo Cesar Ribeiro 41 (3): 205-12. Giglio, Joel Sales 41 (3): 205-12:
Baser, Ray 41 (4): 369-77. Gleghorn, Alice 41 (3): 297-304.
Benguettat, Djamel 41 (1): 1-10." Graap, Ken M. 41 (2): 105-12.
Blagrove, M. 41 (4): 323-29. Greif, Geoffrey L. 41 (4): 387-90.
Bogenschutz, Michael P. 41 (1): 49-60. Grubbs, Laura E. 41 (3): 213-17.
Bonn-Miller, Marcel O. 41 (4): 331-36. Guydish, Joseph 41 (3): 297-304.
Bordnick, Patrick S. 41 (2): 105-12. Hall, Martin T. 41 (2): 135-43.
Broers, Barbara 41 (1): 1-10. Hansen, Katherine 41 (3): 241-48.
Brown, Barry S. 41 (2): 145-52, 41 (3): 285-96. Heilig, Steve'41 (1): 103.
Butler, Rachael 41 (1): 11-17. Hernitche, Ted 41 (4): 355-61.
Carter, Brian L. 41 (2): 105-12. Howard, Matthew O. 41 (2): 135-43, (4): 337-
Cazorla, Irene Mauricio 41 (3): 205-12. Hullsiek, Brad 41 (3): 241-48.
Chaudhry, Saleha Z. 41 (1): 61-66. Jacinto, Camille 41 (1): 27-37.
Chen, Gila 41 (3): 255-66. Jackson, James S. 41 (4): 369-77.
Conner, Kenneth R. 41 (1): 93-98. Jason, Leonard A. 41 (4): 349-54.
Copp, Hilary L. 41 (2): 105-12. Johnson, Bruce D. 41 (3): 219-26.
Coviello, Donna M. 41 (2): 173-80, 189-97. Johnson, J. Aaron 41 (3): 275-83.
Cullen, Jim 41 (4): 391-94. Jones, Katy A. 41 (4): 323-29.
Czuchry, Michael 41 (2): 181-87, (3): 267-73. Kelly, Brian C. 41 (1): 19-26.
Dalbudak, Ercan 41 (1): 85-92. Kelly, Sharon M. 41 (2): 145-52, 41 (3): 285-96.
Dannaway, Frederick 41 (1): 67-84. Khan, Riaz 41 (1): 1-10.
Dansereau, Donald F. 41 (2): 181-87, 41 (3): 267-73. Khazaai, Yasser 41 (1): 1-10.
Davis, Thomas 41 (3): 297-304. Kjellgren, Anette 41 (4): 309-15.
de Rios, Marlene Dobkin 41 (4): 317-22. Klein, Hugh 41 (2): 113-20.
Denson, Raymond 41 (2): 199-202. Klimo, Jon 41 (2): 121-34.
Domis, Sarah W. 41 (2): 189-97. Knudsen, Hannah K. 41 (3): 275-83.
Doukas, Nick 41 (4): 391-94. Kotarba, Joseph A. 41 (3): 219-26.
Ducharme, Lori J. 41 (3): 275-83. Krippner, Stanley 41 (2): 121-34.
Dunlap, Eloise 41 (3): 219-26. Lloyd, Jacqueline J. 41 (2): 173-80.
Duterte, Micheline4 1 (1): 27-37. Lott, Jason P. 41 (3): 305-07.
Dye, Meredith Huey 41 (3): 275-83. Malone, A. Cate 41 (3): 241-48.
Elifson, Kirk W. 41 (2): 113-20. Manghi, Rita Annoni 41 (1): 1-10.
Eriksson, Anders 41 (4): 309-15. Marlowe, Douglas B. 41 (3): 305-07.
Journal of Psychoactive Drugs Volume 41 (4), December 2009
Index Volume 41 (2009)
Marrari, Erica A. 41 (3): 285-96.
Meldrum, Sean C. 41 (1): 93-98.
Mitchell, Shannon Gwin 41 (2): 145-52, 41 (3): 285-96.
Mueller, David G. 41 (4): 349-54 AYAHUASCA
Muli, Victoria 41 (3): 241-48 Changes in spirituality among ayahuasca ceremony novice
Murphy, Sheigla 41 (1): 27-37 participants. Trichter, S.; Klimo, J. & Krippner, S. 41 (2):
Nazar, Barry L. 41 (2): 173-80 121-34.
Neighbors, Harold W. 41 (4): 369-77. Experiences of encounters with ayahuasca—‘“the vine of
Newbern-McFarland, Dianna 41 (2): 181-87 the soul”. Kjellgren, A.; Eriksson, A. & Norlander, T. 41
Norlander, Torsten 41 (4): 309-15. (4): 309-15.
O’Grady, Kevin E. 41 (3): 285-96 A six-month prospective evaluation of personality traits,
Oggins, Jean 41 (2): 163-71 psychiatric symptoms and quality of life in ayahuasca-naive
Oncu, Fatih 41 (1): 85-92 subjects. Barbosa, P.C.R.; Cazorla, I.M.; Giglio, J.S. &
Ozcelik, Basak 41 (1): 85-92 Strassman, R. 41 (3): 205-12.
Parrott, A.C. 41 (4): 323-29.
Peles, Einat 41 (3): 249-5 2 CANNABIS
Perron, Brian E. 41 (4): 337-47, 369-77. Cannabis and Ecstasy/ MDMA: Empirical measures of
Peterson, James A. 41 (2): | creativity in recreational users. Jones, K.A.; Blagrove, M.
Polcin, Douglas L. 41 (2): 153-6 & Parrott, A.C. 41 (4): 323-29.
Potik, David 41 (3): 249-53 Marijuana use, abuse, and dependence: Evaluation of panic
Quintero, Gilbert 41 (1): 39-47 responsivity to biological challenge. Bonn-Miller, M.O. &
Rao, Sandhya R. 41 (3): 267-73 Zvolensky, M.J. 41 (4): 331-36.
Reisinger, Heather Schacht 41 (2): 145-52, 41 (3): 285-96. Reactivity to cannabis cues in virtual reality environments.
Riehman, Kara S. 41 (4): 363-68 Bordnick, P.S.; Copp, H.L.; Traylor, A,; Graap, K.M.; Carter,
Roman, Paul M. 41 (3): 275-83 B.L.; Walton, A. & Ferrer, M. 41 (2): 105-12.
Ross, Mary Ellen 41 (1): 93-98.
Ryan, Steve 41 (3): 241-48 CRIMINAL JUSTICE
Sales, Paloma 41 (1): 27-37 Incarceration and opioid withdrawal: The experiences of
Schreiber, Shaul 41 (3): 249-53 methadone patients and out-of-treatment heroin users.
Schurig, Michelle L. 41 (4): 363-68. Mitchell, S.G.; Kelly, S.M.; Brown, B.S.; Reisinger, H.S.;
Schwartz, Robert P. 41 (2): 145-52, 41 (3): 285-96. Peterson, J.A.; Ruhf, A.; Agar, M.H. & Schwartz, R.P. 41
Scorzelli, James F. 41 (1): 61-66. (2): 145-52.
Sears, Clare 41 (3): 297-304. Predictors of drug treatment completion among parole viola-
Sheridan, Janie 41 (1): 11-17. tors. Zanis, D.A.; Coviello, D.M.; Lloyd, J.J. & Nazar, B.L.
Siddiqui, Nadia 41 (4): 355-61. 41 (2): 173-80.
Spiller, Henry A. 41 (1): 99-102.
Stephens, Robert L. 41 (4): 363-68. ECSTASY (MDMA)
Sterk, Claire E. 41 (2): 113-20. Cannabis and Ecstasy/ MDMA: Empirical measures of
Strassman, Rick 41 (3): 205-12. creativity in recreational users. Jones, K.A.; Blagrove, M.
Sworts, Luke M. 41 (1): 93-98. & Parrott, A.C. 41 (4): 323-29.
Taylor, Robert Joseph 41 (4): 369-77. Mediating MDMA-related harm: Preloading and post-load-
Traylor, Amy (2): 105-12. ing among Ecstasy-using youth. Kelly, B.C. 41 (1): 19-26.
Trichter, Stephen 41 (2): 121-34. Movement disorders and MDMA abuse. Wilcox, J.A. &
Walton, Alicia 41 (2): 105-12. Wilcox, A.H. 41 (2): 203-04.
Watanabe-Galloway, Shinobu 41 (3): 241-48. What’s in a label? Ecstasy sellers’ perceptions of pill brands.
Watkins, Daphne 41 (4): 369-77. Duterte, M.; Jacinto, C.; Sales, P. & Murphy, S. 41 (1):
Weidner, Robert R. 41 (3): 227-39. 27-37.
Wesnoski, Susan A. 41 (2): 189-97. Young adult Ecstasy users’ enhancement of the effects of
Wesson, Donald 41 (1): 104. their Ecstasy use. Klein, H.; Elifson, K.W. & Sterk, C.E.
Wheeler, Amanda 41 (1): 11-17. 41 (2): 113-20.
Wilcox, Aidee Herrera 41 (2): 203-04.
Wilcox, James Allen 41 (2): 203-04. GENDER
Zanis, Dave A. 41 (2): 173-80, 189-97. Gender differences in crime, drug addiction, abstinence,
Zullino, Daniele Fabio 41 (1): 1-10. personality characteristics, and négative emotions. Chen,
Zvolensky, Michael J. 41 (4): 331-36. G. 41 (3): 255-66.
Journal of Psychoactive Drugs Volume 41 (4), December 2009
Index Volume 41 (2009)
Gender differences in psychosocial functioning across Substance use patterns and mental health diagnosis among
substance abuse treatment. Rao, $.R.; Czuchry, M. & Dan- youth in mental health treatment: A latent class analysis.
sereau, D.F. 41 (3): 267-7313 Riehman, K.S.; Stephens, R.L. & Schurig, M.L. 41 (4):
363-68.
HALLUCINOGENS
Alter ego representations in San Agustin monolithic sculp- METHADONE
tures: Possible plant hallucinogenic influences. de Rios, Incarceration and opioid withdrawal: The experiences of
M.D. 41 (4): 317-22. methadone patients and out-of-treatment heroin users.
Thunder among the pines: Defining a pan-Asian soma. Dan- Mitchell, S.G.; Kelly, S.M.; Brown, B.S.; Reisinger, H.S.;
naway, F. 41 (1): 67-84 Peterson, J.A.; Ruhf, A.; Agar, M.H. & Schwartz, R.P. 41
(2): 145-52
HIV An integrated drug counseling and employment interven
Engaging minority men at HIV risk in integrated mental tion for methadone clients. Coviello, D.M.; Zanis, D.A.;
health and drug treatment. Oggins, J. 41 (2): 163-71. Wesnoski, S.A. & Domis, S.W. 41 (2): 189-97.
Premature discharge from methadone treatment: Patient
INHALANTS perspectives. Reisinger, H.S.; Schwartz, R.P.; Mitchell, S.G.;
Nitrite inhalant abuse in antisocial youth: Prevalence, pat- Peterson, J.A.; Kelly, S.M.; O’Grady, K.E.; Marrari, E.A.;
terns, and predictors. Hall, M.T. & Howard, M.O. 41 (2): Brown, B.S. & Agar, M.H. 41 (3): 285-96.
135-43. Reliability of the Lifetime Inventory of Drug Use Conse-
Nitrous oxide inhalation among adolescents: Prevalence, quences (Induc) in methadone maintenance patients. Conner,
correlates, and co-occurrence with volatile solvent inhala- K.R.; Ross, M.E.; Baciewicz, G.; Sworts, L.M. & Meldrum,
tion. Garland, E.L.; Howard, .O. & Perron, B.E. 41 (4): S.C. 41 (1): 93-98.
337-47. Sense of coherence as a stable predictor for methadone mainte
nance treatment (MMT) outcome. Abramsohn, Y.; Peles, E.;
ILLICIT DRUGS : Potik, D.; Schreiber, S. & Adelson, M.41 (3): 249-53.
Making connections: New Orleans evacuees’ experiences in
obtaining drugs. Dunlap, E.; Johnson, B.D.; Kotarba, J.A. METHAMPHETAMINE
Fackler, J. 41 (3): 219-26. Effects of methamphetamine abuse beyond individual users.
Watanabe-Galloway, S.; Ryan, S.; Hansen, K.; Hullsiek, B.;
KHAT Muli, V. & Malone, A.C. 41 (3): 241-48.
Khat use: Lifestyle or addiction? Manghi, R.A.; Broers, [Initiation into methamphetamine use: Qualitative findings
B.; Khan, R.; Benguettat, D.; Khazaal, Y. & Zullino, D.F. from an exploration of first time use among a group of
41 (1): 1-10. New Zealand users. Sheridan, J.; Butler, R. & Wheeler, A.
41 (1): 11-17.
LETTERS TO THE EDITOR Methamphetamine in three small midwestern cities: Evi-
Letter to the editor. Heilig, Steve 41 (1): 103. dence of a moral panic. Weidner, R.R. 41 (3): 227-39.
Letter to the editor. Wesson, Donald 41 (1): 104.
MINORITIES
MENTAL HEALTH Engaging minority men at HIV risk in integrated mental
Childhood abuse and neglect as a risk factor for alexithymia health and drug treatment. Oggins, J. 41 (2): 163-71.
in adult male substance dependent inpatients. Evren, C.; Ethnic differences in delays to treatment for substance use
Evren, B.; Dalbudak, E.; Ozcelik, B. & Oncu, F. 41 (1): disorders: African Americans, Black Caribbeans and non-
85-92. Hispanic Whites. Perron, B.E.; Alexander-Eitzman, B.,;
Engaging minority men at HIV risk in integrated mental Watkins, D.; Taylor, Robert J.; Baser, R.; Neighbors, H.W.
health and drug treatment. Oggins, J. 41 (2): 163-71. & Jackson, J.S. 41 (4): 369-77.
Relationship between anxiety and addiction to a depressant
drug. Scorzelli, J.F. & Chaudhry, S.Z. 41 (1): 61-66. NARCOTHERAPY
A six-month prospective evaluation of personality traits, Narcotherapy in the treatment of post-traumatic stress disor-
psychiatric symptoms and quality of life in ayahuasca-naive ders: A report of two cases. Denson, R. 41 (2): 199-202.
subjects. Barbosa, P.C.R.; Cazorla, I.M..; Giglio, J.S. &
Strassman, R. 41 (3): 205-12. OPIOIDS
Staff perspectives on modified therapeutic community ser- Incarceration and opioid withdrawal: The experiences of
vices for homeless dually diagnosed clients: An exploratory methadone patients and out-of-treatment heroin users. Mitch-
pilot study. Siddiqui, N.; Astone-Twerell, J. & Hernitche, ell, S.G.; Kelly, S.M.; Brown, B.S.; Reisinger, H.S.; Peterson,
T. 41 (4): 355-61. . J.A.; Ruhf, A.; Agar, M.H. & Schwartz, R.P. 41 (2): 145-52.
Journal of Psychoactive Drugs 397 Volume 41 (4), December 2009
Volume 41 (2009)
Relationship of unemployment rate and rate of opiate ex- A model for sober housing during outpatient treatment.
posure in Kentucky. Gascon, D.J. & Spiller, H.A. 41 (1): Polcin, D.L. 41 (2): 153-61.
99-102. Modified therapeutic communities and adherence to tradi-
A review of the Community Reinforcement Approach in tional elements. Dye, M.H.; Ducharme, L.J.; Johnson, J.A.;
the treatment of opioid dependence. Abbott, P.J. 41 (4): Knudsen, H.K. & Roman, P.M. 41 (3): 275-83.
379-85. Predictors of drug treatment completion among parole viola-
tors. Zanis, D.A.; Coviello, D.M.; Lloyd, J.J. & Nazar, B.L.
POLYDRUG USE 41 (2): 173-80.
Controlled release: A cultural analysis of collegiate polydrug A review of the Community Reinforcement Approach in
use. Quintero, G. 41 (1): 39-47. the treatment of opioid dependence. Abbott, P.J. 41 (4):
379-85.
PSILOCYBIN Staff perspectives on modified therapeutic community ser-
Availability of websites offering to sell psilocybin spores vices for homeless dually diagnosed clients: An Exploratory
and psilocybin. Lott, J.P.; Marlowe, D.B. & Forman, R.F. pilot study. Siddiqui, N.; Astone-Twerell, J. & Hernitche,
41 (3): 305-07 T. 41 (4): 355-61.
Substance use patterns and mental health diagnosis among
RECOVERY youth in-mental health treatment: A latent class analysis.
One dozen considerations when working with men in sub- Riehman, K.S.; Stephens, R.L. & Schurig, M.L. 41 (4):
stance abuse groups. Greif, G.L. 41 (4): 387-90. 363-68.
Recovered, in recovery or recovering from substance Visual representation tools for improving addiction treat-
abuse? A question of identity. Doukas, N. & Cullen, J. 41 ment outcomes. Czuchry, M.; Newbern-McFarland, D. &
(4): 391-94 Dansereau, D.F. 41 (2): 181-87.
RESEARCH TREATMENT ON DEMAND :
Pharmacological research on addictions: A framework for Investigating the effects of San Francisco’s Treatment on
ethical and policy considerations. Geppert, C. & Bogen- Demand Initiative on a publicly-funded substance. abuse
schutz, M.P. 41 (1): 49-60. treatment system: A time series analysis. Sears, C.; Davis,
T.; Guydish, J. & Gleghorn, A. 41 (3): 297-304.
SALVIA DIVINORUM
Subjective effects of Salvia divinorum: LSD- or marijuana- YOUTH
like? Albertson, D.N. & Grubbs, L.E. 41 (3): 213-17. Childhood abuse and neglect as a risk factor for alexithymia
in adult male substance dependent inpatients. Evren, C.;
SOBER HOUSING Evren, B.; Dalbudak, E.; Ozcelik, B. & Oncu, F. 41 (1):
A model for sober housing during outpatient treatment. 85-92.
Polcin, D.L. 41 (2): 153-61. Nitrite inhalant abuse in antisocial youth: Prevalence, pat-
Landlords of self-governed recovery homes: An initial terns, and predictors. Hall, M.T. & Howard, M.O. 41 (2):
exploration of attitudes, opinions, and motivation to serve 135-43.
others. Ferrari, J.R.; Aase, D.M.; Mueller, D.G. & Jason, Nitrous oxide inhalation among adolescents: Prevalence,
L.A. 41 (4): 349-54. correlates, and co-occurrence with volatile solvent inhala-
tion. Garland, E.L.; Howard, M.O. & Perron, B.E. 41 (4):
TREATMENT 337-47.
Engaging minority men at HIV risk in integrated mental Substance use patterns and mental health diagnosis among
health and drug treatment. Oggins, J. 41 (2): 163-71. youth in mental health treatment: A latent class analysis.:
Ethnic differences in delays to treatment for substance use Riehman, K.S.; Stephens, R.L. & Schurig, M.L. 41 (4):
disorders: African Americans, Black Caribbeans and non- 363-68.
Hispanic Whites. Perron, B.E.; Alexander-Eitzman, B.;
Watkins, D.; Taylor, Robert J.; Baser, R.; Neighbors, H.W.
& Jackson, J.S. 41 (4): 369-77.
Journal of Psychoactive Drugs Volume 41 (4), December 2009